Home
HEPA
HEPA News

Latest Hepion Pharmaceuticals Inc. (HEPA) News on December 18, 2024

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

GlobeNewswire

7 days ago

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

GlobeNewswire

13 days ago

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

GlobeNewswire

16 days ago

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

GlobeNewswire

a month ago

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

GlobeNewswire

3 months ago

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

GlobeNewswire

5 months ago

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

6 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

6 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

6 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

6 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

6 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

6 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial

GlobeNewswire

8 months ago

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial

Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell

GlobeNewswire

9 months ago

Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

GlobeNewswire

10 months ago

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire

a year ago

Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Globus Maritime Limited Announces the Delivery of a 2024-Built Ultramax Dry Bulk Vessel “Glbs Hero,” Expanding Fleet to Seven Vessels

GlobeNewswire

a year ago

Globus Maritime Limited Announces the Delivery of a 2024-Built Ultramax Dry Bulk Vessel “Glbs Hero,” Expanding Fleet to Seven Vessels

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

GlobeNewswire

a year ago

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

GlobeNewswire

a year ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Business Wire

a year ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

WAVE Charging Sets Industry Milestone with First-Ever OEM-Approved Commercial Wireless Charging Integration in Kenworth's Class 6 Electric Trucks

GlobeNewswire

a year ago

WAVE Charging Sets Industry Milestone with First-Ever OEM-Approved Commercial Wireless Charging Integration in Kenworth's Class 6 Electric Trucks

Urgently Secures Engagement with Global Top 5 Automotive OEM

GlobeNewswire

a year ago

Urgently Secures Engagement with Global Top 5 Automotive OEM

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

PR Newswire

a year ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

Meiwu Technology Co., Limited Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

a year ago

Meiwu Technology Co., Limited Regains Compliance with Nasdaq Listing Requirements

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Business Wire

a year ago

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

EpicQuest Education Announces New Recruiting Initiatives

PR Newswire

a year ago

EpicQuest Education Announces New Recruiting Initiatives

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications

Business Wire

a year ago

ESS Technology to Demonstrate Value of Long-Duration Energy Storage in Military Applications

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Zacks

a year ago

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Inuvo's IntentKey AI Powers the Privacy-First, Post-Cookie Era

GlobeNewswire

a year ago

Inuvo's IntentKey AI Powers the Privacy-First, Post-Cookie Era

Cepton Sets New Industry Benchmark with Next-Generation Flagship Automotive Lidar, Ultra

Business Wire

a year ago

Cepton Sets New Industry Benchmark with Next-Generation Flagship Automotive Lidar, Ultra

Hepion Pharmaceuticals to Present at NASH-TAG 2024

GlobeNewswire

a year ago

Hepion Pharmaceuticals to Present at NASH-TAG 2024

United Security Bancshares's Dividend Analysis

GuruFocus.com

a year ago

United Security Bancshares's Dividend Analysis

Meiwu Technology Co., Limited Reports Unaudited Financial Results for the First Half Fiscal Year of 2023

GlobeNewswire

a year ago

Meiwu Technology Co., Limited Reports Unaudited Financial Results for the First Half Fiscal Year of 2023

Cenntro Electric Group Receives EU Compliance Certifications R155 and R156

Business Wire

a year ago

Cenntro Electric Group Receives EU Compliance Certifications R155 and R156

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

Analysts Say 3 Stocks Have a Combined Upside of 3000%

InvestorPlace

a year ago

Analysts Say 3 Stocks Have a Combined Upside of 3000%

Cepton, Inc. Confirms Receipt of Indication of Interest From Koito Manufacturing Co., Ltd.

Business Wire

a year ago

Cepton, Inc. Confirms Receipt of Indication of Interest From Koito Manufacturing Co., Ltd.

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

PR Newswire

a year ago

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

PR Newswire

a year ago

Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Shareholders Should Be Pleased With Avino Silver & Gold Mines Ltd.'s (TSE:ASM) Price

Simply Wall St.

a year ago

Shareholders Should Be Pleased With Avino Silver & Gold Mines Ltd.'s (TSE:ASM) Price

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

Simply Wall St.

a year ago

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

Presto’s Voice™ AI Solution Projected to Capitalize on Strong Momentum as Company Releases 2024 Projected Annualized Run Rate

GlobeNewswire

a year ago

Presto’s Voice™ AI Solution Projected to Capitalize on Strong Momentum as Company Releases 2024 Projected Annualized Run Rate

Canopy Growth Announces Effective Date of Share Consolidation

CNW Group

a year ago

Canopy Growth Announces Effective Date of Share Consolidation

Inuvo Leads Movement Toward Transparent AI in Advertising

GlobeNewswire

a year ago

Inuvo Leads Movement Toward Transparent AI in Advertising

EpicQuest Education Announces Launch of New Business Segment to Focus on Kinesiology and Recreation Education

PR Newswire

a year ago

EpicQuest Education Announces Launch of New Business Segment to Focus on Kinesiology and Recreation Education

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

GlobeNewswire

a year ago

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes

GlobeNewswire

a year ago

Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

CNW Group

a year ago

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Director Bradley Radoff's Strategic 20,000 Share Acquisition of Harte-Hanks Inc

GuruFocus.com

a year ago

Director Bradley Radoff's Strategic 20,000 Share Acquisition of Harte-Hanks Inc

POET Technologies Issues Letter to Shareholders

GlobeNewswire

a year ago

POET Technologies Issues Letter to Shareholders

Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023

GlobeNewswire

a year ago

Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023

PR Newswire

a year ago

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

Urgently to Participate in Upcoming Investor Conferences

Business Wire

a year ago

Urgently to Participate in Upcoming Investor Conferences

PR Newswire

a year ago

MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%

Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit

GlobeNewswire

a year ago

Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit

authID INC. Announces Closing of $9.4 Million Registered Direct Offering

GlobeNewswire

a year ago

authID INC. Announces Closing of $9.4 Million Registered Direct Offering

MIRA Makes Great Deal for Potential Blockbuster

Zacks Small Cap Research

a year ago

MIRA Makes Great Deal for Potential Blockbuster

Thomas Vo Spends US$114k On Nutex Health Stock

Simply Wall St.

a year ago

Thomas Vo Spends US$114k On Nutex Health Stock

Your Local Newspaper Might Not Have a Single Reporter

The Wall Street Journal

a year ago

Your Local Newspaper Might Not Have a Single Reporter

Gain Therapeutics (GANX) Down 25% on Issue of New Common Stock

Zacks

a year ago

Gain Therapeutics (GANX) Down 25% on Issue of New Common Stock

TechPrecision Corporation (PNK:TPCS) Q2 2024 Earnings Call Transcript

Insider Monkey

a year ago

TechPrecision Corporation (PNK:TPCS) Q2 2024 Earnings Call Transcript

PR Newswire

a year ago

MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time

PR Newswire

a year ago

MIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1a

TechPrecision Corporation Reports Second Quarter 2024 Financial Results

ACCESSWIRE

a year ago

TechPrecision Corporation Reports Second Quarter 2024 Financial Results

PR Newswire

a year ago

MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2

Zacks Small Cap Research

a year ago

SDOT: Sadot Group reports 3rd quarter operating results which showed continued high levels of revenue generation in the core agri-foods subsidiary.

Nicholas Financial Insiders Are Down US$31k But Regain Some Losses

Simply Wall St.

a year ago

Nicholas Financial Insiders Are Down US$31k But Regain Some Losses

Sadot Group Inc. Reports Third Quarter 2023 Results

ACCESSWIRE

a year ago

Sadot Group Inc. Reports Third Quarter 2023 Results

Zacks Small Cap Research

a year ago

MIRA Continues to Pursue New Pain Relief

Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease

GlobeNewswire

a year ago

Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Simply Wall St.

a year ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely

Simply Wall St.

a year ago

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely

Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat

GlobeNewswire

a year ago

Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat

Associated Press Finance

a year ago

Assembly Biosciences: Q3 Earnings Snapshot

Airspan Networks Holdings Inc. Reports Third Quarter 2023 Results

Business Wire

a year ago

Airspan Networks Holdings Inc. Reports Third Quarter 2023 Results

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

GlobeNewswire

a year ago

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

Tritium Implements Strategic Plan to Achieve 2024 Profitability

GlobeNewswire

a year ago

Tritium Implements Strategic Plan to Achieve 2024 Profitability

GuruFocus.com

a year ago

Cognition Therapeutics Inc (CGTX) Reports Q3 2023 Financial Results

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients

GlobeNewswire

a year ago

FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients

Share on Social Networks: